عضو هيئة تدريسية احمد خير الله مهدي

2018 PhD Molecular Pathology Newcastle University , Faculty of Medicine
2007 M.Sc. Histopathology Al-Nahrain University, College of Medicine
2000 M.B.Ch.B (Bachelor in Medicine and General Surgery) Al-Nahrain University, College of Medicine

Presenting pathology lectures to 3rd grade medical students.
Presenting and directing pathology practical lab sessions to 3rd grade medical students and 5th stage surgical pathology

Molecular pathology lectures and labs for postgraduate PhD students

Exploring the effects of targeted anticancer compounds on gene transcription and protein signalling pathways in multiple cancer cell line models using molecular pathology techniques including ShRNA & CRSPR gene editing.
Exploring the effect of ALIOs diet on NAFLD and HCC development in murine animal model.
Exploring the effect of MDM2 and PPM1D/WIP1 inhibitors on liver cancer.

2023 Immunohistochemical expression of CD117 in borderline, low- and high-grade ovarian surface epithelial tumours: A clinicopathological study Malays J Pathol 2023; 45(2) : 229 – 236
2021 Key features of the environment promoting liver cancer in the absence of cirrhosis Scientific Reports; 11, Article number: 16727 (2021)
2018 Targeting negative regulation of p53 by MDM2 and WIP1 as a therapeutic strategy in cutaneous melanoma. British Journal of Cancer; 118, 495-508
2012 PCNA expression in Cag A strain H. Pylori gastritis: immunohistochemical & in situ hybridization study. Iraqi Journal of Medical Sciences., Vol. 10 Issue 2, p160-166. 7p.
2006 Immunohistochemical expression of (CD15, CD20) to reclassify the Lymphocyte Predominance Hodgkin’s Lymphoma. M.Sc. thesis